메뉴 건너뛰기




Volumn 40, Issue 6, 2013, Pages 943-966

18F-Fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type

Author keywords

MIBG; Neuroendocrine tumour; PET CT; Somatostatin receptor scintigraphy

Indexed keywords

(3 IODOBENZYL)GUANIDINE; 5 HYDROXYTRYPTOPHAN; CARBIDOPA; DOPA; FLUORINE 18; FLUORO 18 FLUORODIHYDROXYPHENYLALANINE; FLUORODEOXYGLUCOSE; GALLIUM 68; INDIUM 111; IODINE 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 6 FLUORODOPA F 18; EDOTREOTIDE; FLUORODEOXYGLUCOSE F 18; GALLIUM; OCTREOTIDE; SOMATOSTATIN RECEPTOR; DIAGNOSTIC AGENT; DRUG DERIVATIVE;

EID: 84888342623     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-013-2342-x     Document Type: Review
Times cited : (103)

References (153)
  • 1
    • 29144482046 scopus 로고    scopus 로고
    • Prognostic factors and survival in endocrine tumor patients: Comparison between gastrointestinal and pancreatic localization
    • Panzuto F, Nasoni S, Falconi M, Corleto VD, Capurso G, Cassetta S, et al. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 2005;12:1083-92.
    • (2005) Endocr Relat Cancer , vol.12 , pp. 1083-1092
    • Panzuto, F.1    Nasoni, S.2    Falconi, M.3    Corleto, V.D.4    Capurso, G.5    Cassetta, S.6
  • 2
    • 0032887684 scopus 로고    scopus 로고
    • Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: Bone scintigraphy compared with somatostatin receptor scintigraphy
    • Lebtahi R, Cadiot G, Delahaye N, Genin R, Daou D, Peker MC, et al. Detection of bone metastases in patients with endocrine gastroenteropancreatic tumors: bone scintigraphy compared with somatostatin receptor scintigraphy. J Nucl Med 1999;40(10):1602-8.
    • (1999) J Nucl Med , vol.40 , Issue.10 , pp. 1602-1608
    • Lebtahi, R.1    Cadiot, G.2    Delahaye, N.3    Genin, R.4    Daou, D.5    Peker, M.C.6
  • 3
    • 0027999468 scopus 로고
    • [111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: The predictive value for somatostatin analogue treatment
    • Janson ET,Westlin JE, Eriksson B, Ahlström H, Nilsson S, Öberg K. [111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment. Eur J Endocrinol 1994;131(6):577-81.
    • (1994) Eur J Endocrinol , vol.131 , Issue.6 , pp. 577-581
    • Janson, E.T.1    Westlin, J.E.2    Eriksson, B.3    Ahlström, H.4    Nilsson, S.5    Öberg, K.6
  • 4
    • 0031910371 scopus 로고    scopus 로고
    • Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours
    • Adams S, Baum R, Rink T, Schumm-Dräger PM, Usadel KH, Hör G. Limited value of fluorine-18 fluorodeoxyglucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med 1998;25(1):79-83.
    • (1998) Eur J Nucl Med , vol.25 , Issue.1 , pp. 79-83
    • Adams, S.1    Baum, R.2    Rink, T.3    Schumm-Dräger, P.M.4    Usadel, K.H.5    Hör, G.6
  • 5
    • 0031900605 scopus 로고    scopus 로고
    • Neuroendocrine tumour imaging: Can 18Ffluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior
    • Pasquali C, Rubello D, Sperti C, Gasparoni P, Liessi G, Chierichetti F, et al. Neuroendocrine tumour imaging: can 18Ffluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behavior. World J Surg 1998;22:588-92.
    • (1998) World J Surg , vol.22 , pp. 588-592
    • Pasquali, C.1    Rubello, D.2    Sperti, C.3    Gasparoni, P.4    Liessi, G.5    Chierichetti, F.6
  • 6
    • 0014510423 scopus 로고
    • The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept
    • Pearse AG. The cytochemistry and ultrastructure of polypeptide hormone-producing cells of the APUD series and the embryologic, physiologic and pathologic implications of the concept. J Histochem Cytochem 1969;17(5):303-8.
    • (1969) J Histochem Cytochem , vol.17 , Issue.5 , pp. 303-308
    • Pearse, A.G.1
  • 7
    • 0029971787 scopus 로고    scopus 로고
    • In vivo demonstration of enzyme activity in endocrine pancreatic tumors: Decarboxylation of carbon-11- DOPA to carbon-11-dopamine
    • Bergström M, Eriksson B, Öberg K, Sundin A, Ahlström H, Lindner KJ, et al. In vivo demonstration of enzyme activity in endocrine pancreatic tumors: decarboxylation of carbon-11- DOPA to carbon-11-dopamine. J Nucl Med 1996;37(1):32-7.
    • (1996) J Nucl Med , vol.37 , Issue.1 , pp. 32-37
    • Bergström, M.1    Eriksson, B.2    Öberg, K.3    Sundin, A.4    Ahlström, H.5    Lindner, K.J.6
  • 8
    • 84865304110 scopus 로고    scopus 로고
    • 111In-DTPA0-octreotide (Octreoscan) 131I-MIBG and other agents for radionuclide therapy of NETs
    • Bomanji JB, Papathanasiou ND. 111In-DTPA0-octreotide (Octreoscan), 131I-MIBG and other agents for radionuclide therapy of NETs. Eur J Nucl Med Mol Imaging 2012;39 Suppl 1: S113-25.
    • (2012) Eur J Nucl Med Mol Imaging , vol.39 , Issue.SUPPL. 1
    • Bomanji, J.B.1    Papathanasiou, N.D.2
  • 10
    • 35348832968 scopus 로고    scopus 로고
    • The effects of carbidopa on uptake of 6-18Ffluoro- L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma
    • Timmers HJ, Hadi M, Carrasquillo JA, Chen CC, Martiniova L, Whatley M, et al. The effects of carbidopa on uptake of 6-18Ffluoro- L-DOPA in PET of pheochromocytoma and extraadrenal abdominal paraganglioma. J Nucl Med 2007;48:1599-606.
    • (2007) J Nucl Med , vol.48 , pp. 1599-1606
    • Timmers, H.J.1    Hadi, M.2    Carrasquillo, J.A.3    Chen, C.C.4    Martiniova, L.5    Whatley, M.6
  • 12
    • 55949127644 scopus 로고    scopus 로고
    • Premedication with carbidopa masks positive finding of insulinoma and beta-cell hyperplasia in [(18)F]-dihydroxy-phenyl-alanine positron emission tomography
    • Kauhanen S, Seppänen M, Nuutila P. Premedication with carbidopa masks positive finding of insulinoma and beta-cell hyperplasia in [(18)F]-dihydroxy-phenyl-alanine positron emission tomography. J Clin Oncol 2008;26:5307-8.
    • (2008) J Clin Oncol , vol.26 , pp. 5307-5308
    • Kauhanen, S.1    Seppänen, M.2    Nuutila, P.3
  • 15
    • 84855797559 scopus 로고    scopus 로고
    • Is there an optimal scan time for 6-[F-18] fluoro-L-DOPA PET in pheochromocytomas and paragangliomas?
    • Hentschel M, Rottenburger C, Boedeker CC, Neumann HP, Brink I. Is there an optimal scan time for 6-[F-18]fluoro-L-DOPA PET in pheochromocytomas and paragangliomas? Clin Nucl Med 2012;37(2):e24-9.
    • (2012) Clin Nucl Med , vol.37 , Issue.2
    • Hentschel, M.1    Rottenburger, C.2    Boedeker, C.C.3    Neumann, H.P.4    Brink, I.5
  • 16
    • 77952340573 scopus 로고    scopus 로고
    • Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma
    • Luster M, Karges W, Zeich K, Pauls S, Verburg FA, Dralle H, et al. Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma. Thyroid 2010;20 (5):527-33.
    • (2010) Thyroid , vol.20 , Issue.5 , pp. 527-533
    • Luster, M.1    Karges, W.2    Zeich, K.3    Pauls, S.4    Verburg, F.A.5    Dralle, H.6
  • 20
    • 33750584290 scopus 로고    scopus 로고
    • Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?
    • Montravers F, Grahek D, Kerrou K, Ruszniewski P, de Beco V, Aide N, et al. Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors? J Nucl Med 2006;47(9):1455-62.
    • (2006) J Nucl Med , vol.47 , Issue.9 , pp. 1455-1462
    • Montravers, F.1    Grahek, D.2    Kerrou, K.3    Ruszniewski, P.4    De Beco, V.5    Aide, N.6
  • 21
    • 65249107298 scopus 로고    scopus 로고
    • Impact of fluorodihydroxyphenylalanine- 18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors
    • Montravers F, Kerrou K, Nataf V, Huchet V, Lotz JP, Ruszniewski P, et al. Impact of fluorodihydroxyphenylalanine- 18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors. J Clin Endocrinol Metab 2009;94(4):1295-301.
    • (2009) J Clin Endocrinol Metab , vol.94 , Issue.4 , pp. 1295-1301
    • Montravers, F.1    Kerrou, K.2    Nataf, V.3    Huchet, V.4    Lotz, J.P.5    Ruszniewski, P.6
  • 22
    • 0034746433 scopus 로고    scopus 로고
    • 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels
    • 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med 2001;28:64-71.
    • (2001) Eur J Nucl Med , vol.28 , pp. 64-71
    • Hoegerle, S.1    Altehofer, C.2    Ghanem, N.3    Brink, I.4    Moser, E.5    Nitzsche, E.6
  • 23
    • 84865709685 scopus 로고    scopus 로고
    • Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: A meta-analysis
    • Treglia G, Cocciolillo F, Di Nardo F, Poscia A, de Waure C, Giordano A, et al. Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: a meta-analysis. Acad Radiol 2012;19 (10):1290-9.
    • (2012) Acad Radiol , vol.19 , Issue.10 , pp. 1290-1299
    • Treglia, G.1    Cocciolillo, F.2    Di Nardo, F.3    Poscia, A.4    De Waure, C.5    Giordano, A.6
  • 24
    • 28944433021 scopus 로고    scopus 로고
    • 18F-choline, and 18Ffluoride in bone imaging with emphasis on prostate and breast
    • 18F-choline, and 18Ffluoride in bone imaging with emphasis on prostate and breast. Semin Nucl Med 2006;36:73-92.
    • (2006) Semin Nucl Med , vol.36 , pp. 73-92
    • Langsteger, W.1    Heinisch, M.2    Fogelman, I.3
  • 27
    • 42049103697 scopus 로고    scopus 로고
    • 18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: Relation to tumor differentiation
    • 18F-dihydroxyphenylalanine PET in patients with biochemical evidence of medullary thyroid cancer: relation to tumor differentiation. J Nucl Med 2008;49:524-31.
    • (2008) J Nucl Med , vol.49 , pp. 524-531
    • Koopmans, K.P.1    De Groot Jwb2    Jtm, P.3    De Vries, E.G.4    Kema, I.P.5    Sluiter, W.J.6
  • 28
    • 77949270173 scopus 로고    scopus 로고
    • Dual PET/CT with (18)F-DOPA and (18)FFDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging
    • Marzola MC, Pelizzo MR, Ferdeghini M, Toniato A, Massaro A, Ambrosini V, et al. Dual PET/CT with (18)F-DOPA and (18)FFDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: comparison with conventional imaging. Eur J Surg Oncol 2010;36(4):414-21.
    • (2010) Eur J Surg Oncol , vol.36 , Issue.4 , pp. 414-421
    • Marzola, M.C.1    Pelizzo, M.R.2    Ferdeghini, M.3    Toniato, A.4    Massaro, A.5    Ambrosini, V.6
  • 31
    • 78049336593 scopus 로고    scopus 로고
    • The prognostic value of 2-deoxy-2- [18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma
    • Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Kasperbauer JL, et al. The prognostic value of 2-deoxy-2- [18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma. Mol Imaging Biol 2010;12(5):547-53.
    • (2010) Mol Imaging Biol , vol.12 , Issue.5 , pp. 547-553
    • Bogsrud, T.V.1    Karantanis, D.2    Nathan, M.A.3    Mullan, B.P.4    Wiseman, G.A.5    Kasperbauer, J.L.6
  • 33
    • 84889638082 scopus 로고    scopus 로고
    • Impact de la TEP à la fluoro-(18F)-dihydroxyphénylalanine (FDOPA) sur l'attitude thérapeutique en cas de tumeur endocrine: tumeur digestive cancer médullaire de la thyroïde ou phé ochromocytome
    • Montravers F, Grahek D, Kerrou K, Gutman F, Leverger G, Talbot J. Impact de la TEP à la fluoro-(18F)-dihydroxyphénylalanine (FDOPA) sur l'attitude thérapeutique en cas de tumeur endocrine: tumeur digestive, cancer médullaire de la thyroïde ou phéochromocytome. Med Nucl 2006;30(7):383-9.
    • (2006) Med Nucl , vol.30 , Issue.7 , pp. 383-389
    • Montravers, F.1    Grahek, D.2    Kerrou, K.3    Gutman, F.4    Leverger, G.5    Talbot, J.6
  • 34
    • 72949103236 scopus 로고    scopus 로고
    • Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma
    • Conry BG, Papathanasiou ND, Prakash V, Kayani I, Caplin M, Mahmood S, et al. Comparison of (68)Ga-DOTATATE and (18)F-fluorodeoxyglucose PET/CT in the detection of recurrent medullary thyroid carcinoma. Eur J Nucl Med Mol Imaging 2010;37(1):49-57.
    • (2010) Eur J Nucl Med Mol Imaging , vol.37 , Issue.1 , pp. 49-57
    • Conry, B.G.1    Papathanasiou, N.D.2    Prakash, V.3    Kayani, I.4    Caplin, M.5    Mahmood, S.6
  • 37
    • 0034756055 scopus 로고    scopus 로고
    • Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: Results of a multicentre study
    • Diehl M, Risse JH, Brandt-Mainz K, Dietlein M, Bohuslavizki KH, Matheja P, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography in medullary thyroid cancer: results of a multicentre study. Eur J Nucl Med 2001;28(11):1671-6.
    • (2001) Eur J Nucl Med , vol.28 , Issue.11 , pp. 1671-1676
    • Diehl, M.1    Risse, J.H.2    Brandt-Mainz, K.3    Dietlein, M.4    Bohuslavizki, K.H.5    Matheja, P.6
  • 39
    • 6944231270 scopus 로고    scopus 로고
    • 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer
    • 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer. Ann Surg Oncol 2004;11(8):786-94.
    • (2004) Ann Surg Oncol , vol.11 , Issue.8 , pp. 786-794
    • De Groot, J.W.1    Links, T.P.2    Jager, P.L.3    Kahraman, T.4    Plukker, J.T.5
  • 40
    • 16544377183 scopus 로고    scopus 로고
    • 18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: A clinical study and an analysis of the literature
    • 18F-FDG PET, somatostatin receptor scintigraphy, and CT in metastatic medullary thyroid carcinoma: a clinical study and an analysis of the literature. Nucl Med Commun 2004;25(5):439-43.
    • (2004) Nucl Med Commun , vol.25 , Issue.5 , pp. 439-443
    • Gotthardt, M.1    Battmann, A.2    Höffken, H.3    Schurrat, T.4    Pollum, H.5    Beuter, D.6
  • 41
    • 41949099184 scopus 로고    scopus 로고
    • 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: A prospective study
    • 18F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: a prospective study. Eur J Surg Oncol 2008;34(5):581-6.
    • (2008) Eur J Surg Oncol , vol.34 , Issue.5 , pp. 581-586
    • Rubello, D.1    Rampin, L.2    Nanni, C.3    Banti, E.4    Ferdeghini, M.5    Fanti, S.6
  • 42
    • 84863034134 scopus 로고    scopus 로고
    • (111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents
    • Lodish M, Dagalakis U, Chen CC, Sinaii N, Whitcomb P, Aikin A, et al. (111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents. J Clin Endocrinol Metab 2012;97(2):E207-12.
    • (2012) J Clin Endocrinol Metab , vol.97 , Issue.2
    • Lodish, M.1    Dagalakis, U.2    Chen, C.C.3    Sinaii, N.4    Whitcomb, P.5    Aikin, A.6
  • 43
    • 67749130797 scopus 로고    scopus 로고
    • Medullary thyroid cancer: Management guidelines of the American Thyroid Association
    • American Thyroid Association Guidelines Task Force
    • American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 2009;19(6):565-612.
    • (2009) Thyroid , vol.19 , Issue.6 , pp. 565-612
    • Kloos, R.T.1    Eng, C.2    Evans, D.B.3    Francis, G.L.4    Gagel, R.F.5    Gharib, H.6
  • 45
    • 0026648238 scopus 로고
    • Somatostatin receptor scintigraphy. A simple and sensitive method for the in vivo visualization of Merkel cell tumors and their metastases
    • Kwekkeboom DJ, Hof AM, Lamberts SWJ, Oei HY, Krenning EP. Somatostatin receptor scintigraphy. A simple and sensitive method for the in vivo visualization of Merkel cell tumors and their metastases. Arch Dermatol 1992;128:818-21.
    • (1992) Arch Dermatol , vol.128 , pp. 818-821
    • Kwekkeboom, D.J.1    Hof, A.M.2    Swj, L.3    Oei, H.Y.4    Krenning, E.P.5
  • 46
    • 0007857218 scopus 로고    scopus 로고
    • F-18 FDG accumulation in an octreotide negative Merkel cell tumor
    • Wong CO, Pham AN, Dworkin HJ. F-18 FDG accumulation in an octreotide negative Merkel cell tumor. Clin Positron Imaging 2000;3:71-3.
    • (2000) Clin Positron Imaging , vol.3 , pp. 71-73
    • Wong, C.O.1    Pham, A.N.2    Dworkin, H.J.3
  • 47
    • 33646791165 scopus 로고    scopus 로고
    • 6-[F-18]Fluoro-L-DOPA positron emission tomography in the imaging of Merkel cell carcinoma: Preliminary report of three cases with 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography or pentetreotide-(111In) SPECT data
    • Talbot JN, Kerrou K, Missoum F, Grahek D, Aide N, Lumbroso J, et al. 6-[F-18]Fluoro-L-DOPA positron emission tomography in the imaging of Merkel cell carcinoma: preliminary report of three cases with 2-deoxy-2-[F-18]fluoro-D- glucose positron emission tomography or pentetreotide-(111In) SPECT data. Mol Imaging Biol 2005;7(4):257-61.
    • (2005) Mol Imaging Biol , vol.7 , Issue.4 , pp. 257-261
    • Talbot, J.N.1    Kerrou, K.2    Missoum, F.3    Grahek, D.4    Aide, N.5    Lumbroso, J.6
  • 48
    • 76549115351 scopus 로고    scopus 로고
    • Diagnostic imaging in Merkel cell carcinoma: Lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET
    • Peloschek P, Novotny C, Mueller-Mang C, Weber M, Sailer J, Dawid M, et al. Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET. Eur J Radiol 2010;73(2):317-23.
    • (2010) Eur J Radiol , vol.73 , Issue.2 , pp. 317-323
    • Peloschek, P.1    Novotny, C.2    Mueller-Mang, C.3    Weber, M.4    Sailer, J.5    Dawid, M.6
  • 49
    • 84869100490 scopus 로고    scopus 로고
    • The predictive value of imaging studies in evaluating regional lymph node involvement in Merkel cell carcinoma
    • Colgan MB, Tarantola TI, Weaver AL, Wiseman GA, Roenigk RK, Brewer JD, et al. The predictive value of imaging studies in evaluating regional lymph node involvement in Merkel cell carcinoma. J Am Acad Dermatol 2012;67(6):1250-6.
    • (2012) J Am Acad Dermatol , vol.67 , Issue.6 , pp. 1250-1256
    • Colgan, M.B.1    Tarantola, T.I.2    Weaver, A.L.3    Wiseman, G.A.4    Roenigk, R.K.5    Brewer, J.D.6
  • 50
  • 53
    • 0035096765 scopus 로고    scopus 로고
    • Positron emission tomography in the staging of smallcell lung cancer: A preliminary study
    • Hauber HP, Bohuslaviki KH, Lund CH, Fritscher-Ravens A, Meyer A, Pforte A. Positron emission tomography in the staging of smallcell lung cancer: a preliminary study. Chest 2001;119(3):950-4.
    • (2001) Chest , vol.119 , Issue.3 , pp. 950-954
    • Hauber, H.P.1    Bohuslaviki, K.H.2    Lund, C.H.3    Fritscher-Ravens, A.4    Meyer, A.5    Pforte, A.6
  • 54
    • 12444304202 scopus 로고    scopus 로고
    • Positron emission tomography with [(18)F]FDOPA and [(18)F]FDG in the imaging of small cell lung carcinoma: Preliminary results
    • Jacob T, Grahek D, Younsi N, Kerrou K, Aide N, Montravers F, et al. Positron emission tomography with [(18)F]FDOPA and [(18)F]FDG in the imaging of small cell lung carcinoma: preliminary results. Eur J Nucl Med Mol Imaging 2003;30:1266-9.
    • (2003) Eur J Nucl Med Mol Imaging , vol.30 , pp. 1266-1269
    • Jacob, T.1    Grahek, D.2    Younsi, N.3    Kerrou, K.4    Aide, N.5    Montravers, F.6
  • 56
    • 36849015417 scopus 로고    scopus 로고
    • A pulmonary adrenocorticotropin-secreting carcinoid tumor localized by 6-fluoro-[18F]L-dihydroxyphenylalanine positron emission/computed tomography imaging in a patient with Cushing's syndrome
    • Dubois S, Morel O, Rodien P, Illouz F, Girault S, Cahouet A, et al. A pulmonary adrenocorticotropin-secreting carcinoid tumor localized by 6-fluoro-[18F]L-dihydroxyphenylalanine positron emission/computed tomography imaging in a patient with Cushing's syndrome. J Clin Endocrinol Metab 2007;92:4512-3.
    • (2007) J Clin Endocrinol Metab , vol.92 , pp. 4512-4513
    • Dubois, S.1    Morel, O.2    Rodien, P.3    Illouz, F.4    Girault, S.5    Cahouet, A.6
  • 61
    • 33846315063 scopus 로고    scopus 로고
    • The utility of fluorodeoxyglucose emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules
    • Daniels CE, Lowe VJ, Aubry MC, Allen MS, Jett JR. The utility of fluorodeoxyglucose emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules. Chest 2007;131(1):255-60.
    • (2007) Chest , vol.131 , Issue.1 , pp. 255-260
    • Daniels, C.E.1    Lowe, V.J.2    Aubry, M.C.3    Allen, M.S.4    Jett, J.R.5
  • 64
    • 79960493573 scopus 로고    scopus 로고
    • Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids
    • Jindal T, Kumar A, Venkitaraman B, Meena M, Kumar R, Malhotra A, et al. Evaluation of the role of [18F]FDG-PET/CT and [68Ga]DOTATOC-PET/CT in differentiating typical and atypical pulmonary carcinoids. Cancer Imaging 2011;11:70-5.
    • (2011) Cancer Imaging , vol.11 , pp. 70-75
    • Jindal, T.1    Kumar, A.2    Venkitaraman, B.3    Meena, M.4    Kumar, R.5    Malhotra, A.6
  • 65
    • 50549199830 scopus 로고
    • The classification of carcinoid tumours
    • Williams ED, Sandler M. The classification of carcinoid tumours. Lancet 1963;i:238-9.
    • (1963) Lancet , vol.1 , pp. 238-239
    • Williams, E.D.1    Sandler, M.2
  • 67
    • 0035528831 scopus 로고    scopus 로고
    • 6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma
    • Pacak K, Eisenhofer G, Carrasquillo JA, Chen CC, Li ST, Goldstein DS. 6-[18F]fluorodopamine positron emission tomographic (PET) scanning for diagnostic localization of pheochromocytoma. Hypertension 2001;38:6-8.
    • (2001) Hypertension , vol.38 , pp. 6-8
    • Pacak, K.1    Eisenhofer, G.2    Carrasquillo, J.A.3    Chen, C.C.4    Li, S.T.5    Goldstein, D.S.6
  • 68
    • 34247179545 scopus 로고    scopus 로고
    • Whole-body PET/CT with 11C-metahydroxyephedrine in tumors of the sympathetic nervous system: Feasibility study and comparison with 123I-MIBG SPECT/CT
    • Franzius C, Hermann K, Weckesser M, Kopka K, Juergens KU, Vormoor J, et al. Whole-body PET/CT with 11C-metahydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT. J Nucl Med 2006;47(10):1635-42.
    • (2006) J Nucl Med , vol.47 , Issue.10 , pp. 1635-1642
    • Franzius, C.1    Hermann, K.2    Weckesser, M.3    Kopka, K.4    Juergens, K.U.5    Vormoor, J.6
  • 69
    • 84863595048 scopus 로고    scopus 로고
    • 11CHydroxyephedrine positron emission tomography imaging of pheochromocytoma: A single center experience over 11 years
    • Yamamoto S, Hellman P, Wassberg C, Sundin A. 11CHydroxyephedrine positron emission tomography imaging of pheochromocytoma: a single center experience over 11 years. J Clin Endocrinol Metab 2012;97(7):2423-32.
    • (2012) J Clin Endocrinol Metab , vol.97 , Issue.7 , pp. 2423-2432
    • Yamamoto, S.1    Hellman, P.2    Wassberg, C.3    Sundin, A.4
  • 70
  • 72
    • 65549141729 scopus 로고    scopus 로고
    • The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors
    • Kauhanen S, Seppänen M, Ovaska J, Minn H, Bergman J, Korsoff P, et al. The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors. Endocr Relat Cancer 2009;16:255-65.
    • (2009) Endocr Relat Cancer , vol.16 , pp. 255-265
    • Kauhanen, S.1    Seppänen, M.2    Ovaska, J.3    Minn, H.4    Bergman, J.5    Korsoff, P.6
  • 74
    • 70349904742 scopus 로고    scopus 로고
    • 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess
    • Fiebrich HB, Brouwers AH, Kerstens MN, Pijl ME, Kema IP, de Jong JR, et al. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess. J Clin Endocrinol Metab 2009;94 (10):3922-30.
    • (2009) J Clin Endocrinol Metab , vol.94 , Issue.10 , pp. 3922-3930
    • Fiebrich, H.B.1    Brouwers, A.H.2    Kerstens, M.N.3    Pijl, M.E.4    Kema, I.P.5    De Jong, J.R.6
  • 76
    • 78650369777 scopus 로고    scopus 로고
    • Comparison of [111In]pentetreotide-SPECT and [18F] FDOPA-PET in the localization of extra-adrenal paragangliomas: The case for a patient-tailored use of nuclear imaging modalities
    • Charrier N, Deveze A, Fakhry N, Sebag F, Morange I, Gaborit B, et al. Comparison of [111In]pentetreotide-SPECT and [18F] FDOPA-PET in the localization of extra-adrenal paragangliomas: the case for a patient-tailored use of nuclear imaging modalities. Clin Endocrinol (Oxf) 2011;74(1):21-9.
    • (2011) Clin Endocrinol (Oxf) , vol.74 , Issue.1 , pp. 21-29
    • Charrier, N.1    Deveze, A.2    Fakhry, N.3    Sebag, F.4    Morange, I.5    Gaborit, B.6
  • 77
    • 77954462618 scopus 로고    scopus 로고
    • 18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: Correlation with vesicular monoamine transporter expression
    • 18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression. J Clin Endocrinol Metab 2010;95(6):2800-10.
    • (2010) J Clin Endocrinol Metab , vol.95 , Issue.6 , pp. 2800-2810
    • Fottner, C.1    Helisch, A.2    Anlauf, M.3    Rossmann, H.4    Musholt, T.J.5    Kreft, A.6
  • 79
    • 79958772264 scopus 로고    scopus 로고
    • Comparison of 123I-MIBG SPECT-CT and 18FDOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma
    • Rufini V, Treglia G, Castaldi P, Perotti G, Calcagni ML, Corsello SM, et al. Comparison of 123I-MIBG SPECT-CT and 18FDOPA PET-CT in the evaluation of patients with known or suspected recurrent paraganglioma. Nucl Med Commun 2011;32:575-82.
    • (2011) Nucl Med Commun , vol.32 , pp. 575-582
    • Rufini, V.1    Treglia, G.2    Castaldi, P.3    Perotti, G.4    Calcagni, M.L.5    Corsello, S.M.6
  • 81
    • 84862668094 scopus 로고    scopus 로고
    • Diagnostic performance of 18Fdihydroxyphenylalanine positron emission tomography in patients with paraganglioma: A meta-analysis
    • Treglia G, Cocciolillo F, de Waure C, Di Nardo F, Gualano MR, Castaldi P, et al Diagnostic performance of 18Fdihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis. Eur J Nucl Med Mol Imaging 2012;39(7):1144-53.
    • (2012) Eur J Nucl Med Mol Imaging , vol.39 , Issue.7 , pp. 1144-1153
    • Treglia, G.1    Cocciolillo, F.2    De Waure, C.3    Di Nardo, F.4    Gualano, M.R.5    Castaldi, P.6
  • 85
    • 0026654449 scopus 로고
    • In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas
    • Reubi JC, Waser B, Khosla S, Kvols L, Goellner JR, Krenning E, et al. In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas. J Clin Endocrinol Metab 1992;74:1082-9.
    • (1992) J Clin Endocrinol Metab , vol.74 , pp. 1082-1089
    • Reubi, J.C.1    Waser, B.2    Khosla, S.3    Kvols, L.4    Goellner, J.R.5    Krenning, E.6
  • 87
    • 84892911144 scopus 로고    scopus 로고
    • Evaluation of the impact of FDOPA-PET on the management of patients referred for pheochromocytoma
    • Montravers F, Kerrou K, Huchet V, Nataf V, Talbot JN. Evaluation of the impact of FDOPA-PET on the management of patients referred for pheochromocytoma. J Nucl Med 2008;49 (Suppl 1):365.
    • (2008) J Nucl Med , vol.49 , Issue.SUPPL. 1 , pp. 365
    • Montravers, F.1    Kerrou, K.2    Huchet, V.3    Nataf, V.4    Talbot, J.N.5
  • 88
    • 33847207873 scopus 로고    scopus 로고
    • Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors
    • Ezziddin S, Logvinski T, Yong-Hing C, Ahmadzadehfar H, Fischer HP, Palmedo H, et al. Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors. J Nucl Med 2006;47:223-33.
    • (2006) J Nucl Med , vol.47 , pp. 223-233
    • Ezziddin, S.1    Logvinski, T.2    Yong-Hing, C.3    Ahmadzadehfar, H.4    Fischer, H.P.5    Palmedo, H.6
  • 89
    • 17744373472 scopus 로고    scopus 로고
    • Comparison of somatostatin analog and metaiodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors
    • Kaltsas G, Korbonits M, Heintz E, Mukherjee JJ, Jenkins PJ, Chew SL, et al. Comparison of somatostatin analog and metaiodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors. J Clin Endocrinol Metab 2001;86:895-902.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 895-902
    • Kaltsas, G.1    Korbonits, M.2    Heintz, E.3    Mukherjee, J.J.4    Jenkins, P.J.5    Chew, S.L.6
  • 90
    • 0033062098 scopus 로고    scopus 로고
    • Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography
    • Hoegerle S, Schneider B, Kraft A, Moser E, Nitzsche EU. Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography. Nuklearmedizin 1999;38(4):127-30.
    • (1999) Nuklearmedizin , vol.38 , Issue.4 , pp. 127-130
    • Hoegerle, S.1    Schneider, B.2    Kraft, A.3    Moser, E.4    Nitzsche, E.U.5
  • 93
    • 0035991806 scopus 로고    scopus 로고
    • Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: Correlations with the pathological indexes p53 and Ki-67
    • Belhocine T, Foidart J, Rigo P, Najjar F, Thiry A, Quatresooz P, et al. Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67. Nucl Med Commun 2002;23:727-34.
    • (2002) Nucl Med Commun , vol.23 , pp. 727-734
    • Belhocine, T.1    Foidart, J.2    Rigo, P.3    Najjar, F.4    Thiry, A.5    Quatresooz, P.6
  • 94
    • 68749092790 scopus 로고    scopus 로고
    • Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F] fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients
    • Fiebrich HB, Brouwers AH, Koopmans KP, de Vries EG. Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F] fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients. Eur J Cancer 2009;45(13):2312-5.
    • (2009) Eur J Cancer , vol.45 , Issue.13 , pp. 2312-2315
    • Fiebrich, H.B.1    Brouwers, A.H.2    Koopmans, K.P.3    De Vries, E.G.4
  • 95
    • 84862640505 scopus 로고    scopus 로고
    • The risk of metachronous cancers in patients with small-intestinal carcinoid tumors: A US population-based study
    • Amin S,Warner RR, Itzkowitz SH, KimMK. The risk of metachronous cancers in patients with small-intestinal carcinoid tumors: a US population-based study. Endocr Relat Cancer 2012;19(3):381-7.
    • (2012) Endocr Relat Cancer , vol.19 , Issue.3 , pp. 381-387
    • Amin, S.1    Warner, R.R.2    Itzkowitz, S.H.3    Kim, M.K.4
  • 98
    • 84892932787 scopus 로고    scopus 로고
    • Comparison of FDOPA (18F) and DOTATOC (68Ga) PET/CT for detection of ileal carcinoid tumours
    • abs OP586
    • Montravers F, Nataf V, Balogova S, Calzada M, Maurel G, Kerrou K, et al. Comparison of FDOPA (18F) and DOTATOC (68Ga) PET/CT for detection of ileal carcinoid tumours. Eur J Nucl Med Mol Imaging 2010;37(S2):S302. abs OP586.
    • (2010) Eur J Nucl Med Mol Imaging , vol.37 , Issue.S2
    • Montravers, F.1    Nataf, V.2    Balogova, S.3    Calzada, M.4    Maurel, G.5    Kerrou, K.6
  • 100
    • 84872826979 scopus 로고    scopus 로고
    • Gastroenteric neuroendocrine neoplasms classification: Comparison of prognostic models
    • Dolcetta-Capuzzo A, Villa V, Albarello L, Franchi GM, Gemma M, Scavini M, et al. Gastroenteric neuroendocrine neoplasms classification: comparison of prognostic models. Cancer 2013;119(1):36-44.
    • (2013) Cancer , vol.119 , Issue.1 , pp. 36-44
    • Dolcetta-Capuzzo, A.1    Villa, V.2    Albarello, L.3    Franchi, G.M.4    Gemma, M.5    Scavini, M.6
  • 101
  • 102
    • 84655175045 scopus 로고    scopus 로고
    • Highgrade neuroendocrine carcinoma of the colon, long-term survival in advanced disease
    • Power DG, Asmis TR, Tang LH, Brown K, Kemeny NE. Highgrade neuroendocrine carcinoma of the colon, long-term survival in advanced disease. Med Oncol 2011;28 Suppl 1:S169-74.
    • (2011) Med Oncol , vol.28 SUPPL. 1
    • Power, D.G.1    Asmis, T.R.2    Tang, L.H.3    Brown, K.4    Kemeny, N.E.5
  • 104
    • 79960296365 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas
    • Wild D, Christ E, Caplin ME, Kurzawinski TR, Forrer F, Brändle M, et al. Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas. J Nucl Med 2011;52(7):1073-8.
    • (2011) J Nucl Med , vol.52 , Issue.7 , pp. 1073-1078
    • Wild, D.1    Christ, E.2    Caplin, M.E.3    Kurzawinski, T.R.4    Forrer, F.5    Brändle, M.6
  • 105
    • 34147154971 scopus 로고    scopus 로고
    • Fluorine-18-L-dihydroxyphenylalanine (18FDOPA) positron emission tomography as a tool to localize an insulinoma or β-cell hyperplasia in adult patients
    • Kauhanen S, Seppänen M, Minn H, Gullichsen R, Salonen A, Alanen K, et al. Fluorine-18-L-dihydroxyphenylalanine (18FDOPA) positron emission tomography as a tool to localize an insulinoma or β-cell hyperplasia in adult patients. J Clin Endocrinol Metab 2007;92:1237-44.
    • (2007) J Clin Endocrinol Metab , vol.92 , pp. 1237-1244
    • Kauhanen, S.1    Seppänen, M.2    Minn, H.3    Gullichsen, R.4    Salonen, A.5    Alanen, K.6
  • 107
    • 77952519078 scopus 로고    scopus 로고
    • Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L- dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients
    • Putzer D, Gabriel M, Kendler D, Henninger B, Knoflach M, Kroiss A, et al. Comparison of (68)Ga-DOTA-Tyr(3)-octreotide and (18)F-fluoro-L- dihydroxyphenylalanine positron emission tomography in neuroendocrine tumor patients. Q J Nucl Med Mol Imaging 2010;54(1):68-75.
    • (2010) Q J Nucl Med Mol Imaging , vol.54 , Issue.1 , pp. 68-75
    • Putzer, D.1    Gabriel, M.2    Kendler, D.3    Henninger, B.4    Knoflach, M.5    Kroiss, A.6
  • 108
    • 79952302230 scopus 로고    scopus 로고
    • Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (≥10 %) well-differentiated endocrine carcinoma staging
    • Abgral R, Leboulleux S, Déandreis D, Aupérin A, Lumbroso J, Dromain C, et al. Performance of (18)fluorodeoxyglucose-positron emission tomography and somatostatin receptor scintigraphy for high Ki67 (≥10 %) well-differentiated endocrine carcinoma staging. J Clin Endocrinol Metab 2011;96(3):665-71.
    • (2011) J Clin Endocrinol Metab , vol.96 , Issue.3 , pp. 665-671
    • Abgral, R.1    Leboulleux, S.2    Déandreis, D.3    Aupérin, A.4    Lumbroso, J.5    Dromain, C.6
  • 109
  • 110
    • 33644782807 scopus 로고    scopus 로고
    • Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography
    • Otonkoski T, Näntö-Salonen K, Seppänen M, Veijola R, Huopio H, Hussain K, et al. Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography. Diabetes 2006;55:13-8.
    • (2006) Diabetes , vol.55 , pp. 13-18
    • Otonkoski, T.1    Näntö-Salonen, K.2    Seppänen, M.3    Veijola, R.4    Huopio, H.5    Hussain, K.6
  • 113
    • 78751518250 scopus 로고    scopus 로고
    • The predictive value of preoperative fluorine-18-L-3,4- dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy
    • Zani A, Nah SA, Ron O, Totonelli G, Ismail D, Smith VV, et al. The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy. J Pediatr Surg 2011;46(1):204-8.
    • (2011) J Pediatr Surg , vol.46 , Issue.1 , pp. 204-208
    • Zani, A.1    Nah, S.A.2    Ron, O.3    Totonelli, G.4    Ismail, D.5    Smith, V.V.6
  • 114
    • 78650492859 scopus 로고    scopus 로고
    • Positron emission tomography/computed tomography diagnostics by means of fluorine-18-L-dihydroxyphenylalanine in congenital hyperinsulinism
    • Mohnike W, Barthlen W, Mohnike K, Blankenstein O. Positron emission tomography/computed tomography diagnostics by means of fluorine-18-L- dihydroxyphenylalanine in congenital hyperinsulinism. Semin Pediatr Surg 2011;20(1):23-7.
    • (2011) Semin Pediatr Surg , vol.20 , Issue.1 , pp. 23-27
    • Mohnike, W.1    Barthlen, W.2    Mohnike, K.3    Blankenstein, O.4
  • 115
    • 84872269935 scopus 로고    scopus 로고
    • Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: A meta-analysis
    • TregliaG,Mirk P, GiordanoA, Rufini V. Diagnostic performance of fluorine-18-dihydroxyphenylalanine positron emission tomography in diagnosing and localizing the focal form of congenital hyperinsulinism: a meta-analysis. Pediatr Radiol 2012;42(11):1372-9.
    • (2012) Pediatr Radiol , vol.42 , Issue.11 , pp. 1372-1379
    • Treglia, G.1    Mirk, P.2    Giordano, A.3    Rufini, V.4
  • 116
    • 84873090830 scopus 로고    scopus 로고
    • The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: Systematic review and meta-analysis
    • Blomberg BA,MoghbelMC, Saboury B, Stanley CA, Alavi A. The value of radiologic interventions and (18)F-DOPA PET in diagnosing and localizing focal congenital hyperinsulinism: systematic review and meta-analysis. Mol Imaging Biol 2013;15:97-105.
    • (2013) Mol Imaging Biol , vol.15 , pp. 97-105
    • Blomberg, B.A.1    Moghbel, M.C.2    Saboury, B.3    Stanley, C.A.4    Alavi, A.5
  • 117
    • 33748186497 scopus 로고    scopus 로고
    • F-18 FDG PET imaging of urinary bladder oat cell carcinoma with widespread osseous metastases
    • Iagaru A, Gamie S, Segall G. F-18 FDG PET imaging of urinary bladder oat cell carcinoma with widespread osseous metastases. Clin Nucl Med 2006;31(8):476-8.
    • (2006) Clin Nucl Med , vol.31 , Issue.8 , pp. 476-478
    • Iagaru, A.1    Gamie, S.2    Segall, G.3
  • 118
    • 35748939974 scopus 로고    scopus 로고
    • Detection of primary and metastatic lesions by [18F]fluoro-2-deoxy-D- glucose PET in a patient with thymic carcinoid
    • Fujishita T, Kishida M, Taki H, Shinoda C, Miyabayashi K, Fujishita M, et al. Detection of primary and metastatic lesions by [18F]fluoro-2-deoxy-D- glucose PET in a patient with thymic carcinoid. Respirology 2007;12(6):928-30.
    • (2007) Respirology , vol.12 , Issue.6 , pp. 928-930
    • Fujishita, T.1    Kishida, M.2    Taki, H.3    Shinoda, C.4    Miyabayashi, K.5    Fujishita, M.6
  • 119
    • 71049183148 scopus 로고    scopus 로고
    • Clinical usefulness of fluoro-2-deoxy-D-glucose PET in a case with multiple bone metastases of carcinoid tumor after ten years
    • Kobashi Y, Shimizu H, Mouri K, Irei T, Oka M. Clinical usefulness of fluoro-2-deoxy-D-glucose PET in a case with multiple bone metastases of carcinoid tumor after ten years. Intern Med 2009;48(21):1919-23.
    • (2009) Intern Med , vol.48 , Issue.21 , pp. 1919-1923
    • Kobashi, Y.1    Shimizu, H.2    Mouri, K.3    Irei, T.4    Oka, M.5
  • 120
    • 78649612713 scopus 로고    scopus 로고
    • Thymic neuroendocrine tumour (carcinoid): Clinicopathological features of four patients with different presentation
    • Dutta R, Kumar A, Julka PK, Mathur SR, Kaushal S, Kumar R, et al. Thymic neuroendocrine tumour (carcinoid): clinicopathological features of four patients with different presentation. Interact Cardiovasc Thorac Surg 2010;11(6):732-6.
    • (2010) Interact Cardiovasc Thorac Surg , vol.11 , Issue.6 , pp. 732-736
    • Dutta, R.1    Kumar, A.2    Julka, P.K.3    Mathur, S.R.4    Kaushal, S.5    Kumar, R.6
  • 121
    • 0036135042 scopus 로고    scopus 로고
    • Diagnosing and treating smallcell carcinomas of prostatic origin
    • Spieth ME, Lin YG, Nguyen TT. Diagnosing and treating smallcell carcinomas of prostatic origin. Clin Nucl Med 2002;27 (1):11-7.
    • (2002) Clin Nucl Med , vol.27 , Issue.1 , pp. 11-17
    • Spieth, M.E.1    Lin, Y.G.2    Nguyen, T.T.3
  • 123
    • 70350119789 scopus 로고    scopus 로고
    • Widespread metastases in small cell carcinoma of the prostate on FDG PET/CT
    • Yilmaz M, Celen Z, Sevinc A, Karakok M. Widespread metastases in small cell carcinoma of the prostate on FDG PET/CT. Clin Nucl Med 2009;34:598-600.
    • (2009) Clin Nucl Med , vol.34 , pp. 598-600
    • Yilmaz, M.1    Celen, Z.2    Sevinc, A.3    Karakok, M.4
  • 125
    • 84855195252 scopus 로고    scopus 로고
    • Complete remission in a patient with metastatic mixed adenocarcinoma/extrapulmonary small cell carcinoma of the prostate
    • Brammer JE, Lulla P, Lynch GR. Complete remission in a patient with metastatic mixed adenocarcinoma/extrapulmonary small cell carcinoma of the prostate. Int J Clin Oncol 2011;16(6):722-5.
    • (2011) Int J Clin Oncol , vol.16 , Issue.6 , pp. 722-725
    • Brammer, J.E.1    Lulla, P.2    Lynch, G.R.3
  • 126
    • 84856723290 scopus 로고    scopus 로고
    • Novel medical therapies of recurrent and metastatic gastroenteropancreatic neuroendocrine tumors
    • Miljkovi? MD, Girotra M, Abraham RR, Erlich RB. Novel medical therapies of recurrent and metastatic gastroenteropancreatic neuroendocrine tumors. Dig Dis Sci 2012;57(1):9-18.
    • (2012) Dig Dis Sci , vol.57 , Issue.1 , pp. 9-18
    • Miljkovi, M.D.1    Girotra, M.2    Abraham, R.R.3    Erlich, R.B.4
  • 128
    • 40849114945 scopus 로고    scopus 로고
    • Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases
    • Schmitt AM, Riniker F, AnlaufM, Schmid S, Soltermann A,Moch H, et al. Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases. Am J Surg Pathol 2008;32(3):420-5.
    • (2008) Am J Surg Pathol , vol.32 , Issue.3 , pp. 420-425
    • Schmitt, A.M.1    Riniker, F.2    Anlauf, M.3    Schmid, S.4    Soltermann, A.5    Moch, H.6
  • 129
    • 84859888884 scopus 로고    scopus 로고
    • PDX-1 CDX-2 TTF-1, and CK7: A reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms
    • Chan ES, Alexander J, Swanson PE, Jain D, Yeh MM. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms. Am J Surg Pathol 2012;36(5):737-43.
    • (2012) Am J Surg Pathol , vol.36 , Issue.5 , pp. 737-743
    • Chan, E.S.1    Alexander, J.2    Swanson, P.E.3    Jain, D.4    Yeh, M.M.5
  • 130
    • 78349282294 scopus 로고    scopus 로고
    • 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors
    • 68Ga-DOTATOC positron emission tomography/computed tomography on the multimodal management of patients with neuroendocrine tumors. Ann Surg 2010;252(5):850-6.
    • (2010) Ann Surg , vol.252 , Issue.5 , pp. 850-856
    • Frilling, A.1    Sotiropoulos, G.C.2    Amalagom, R.3    Bockisch, A.4    Kuehl, H.5
  • 131
    • 72949100074 scopus 로고    scopus 로고
    • Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT
    • Prasad V, Ambrosini V, Hommann M, Hoersch D, Fanti S, Baum RP. Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT. Eur J Nucl Med Mol Imaging 2010;37(1):67-77.
    • (2010) Eur J Nucl Med Mol Imaging , vol.37 , Issue.1 , pp. 67-77
    • Prasad, V.1    Ambrosini, V.2    Hommann, M.3    Hoersch, D.4    Fanti, S.5    Baum, R.P.6
  • 134
    • 84865613008 scopus 로고    scopus 로고
    • 68Ga-DOTA-TOC PET/CT revealed the underlying cause of ectopic Cushing syndrome
    • 68Ga-DOTA-TOC PET/CT revealed the underlying cause of ectopic Cushing syndrome. Clin Nucl Med 2012;37(9):904-5.
    • (2012) Clin Nucl Med , vol.37 , Issue.9 , pp. 904-905
    • Schalin-Jäntti, C.1    Ahonen, A.2    Seppänen, M.3
  • 135
    • 17744381182 scopus 로고    scopus 로고
    • [18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome
    • Markou A,Manning P, Kaya B,Datta SN, Bomanji JB, Conway GS. [18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome. Eur J Endocrinol 2005;152(4):521-5.
    • (2005) Eur J Endocrinol , vol.152 , Issue.4 , pp. 521-525
    • Markou, A.1    Manning, P.2    Kaya, B.3    Datta, S.N.4    Bomanji, J.B.5    Conway, G.S.6
  • 138
    • 78049347762 scopus 로고    scopus 로고
    • The value of 11C-5-hydroxytryptophan positron emission tomography in neuroendocrine tumor diagnosis and management: Experience from one center
    • Nikolaou A, Thomas D, Kampanellou C, Alexandraki K, Andersson LG, Sundin A, et al. The value of 11C-5-hydroxytryptophan positron emission tomography in neuroendocrine tumor diagnosis and management: experience from one center. J Endocrinol Invest 2010;33(11):794-9.
    • (2010) J Endocrinol Invest , vol.33 , Issue.11 , pp. 794-799
    • Nikolaou, A.1    Thomas, D.2    Kampanellou, C.3    Alexandraki, K.4    Andersson, L.G.5    Sundin, A.6
  • 139
    • 77956960802 scopus 로고    scopus 로고
    • Ectopic Cushing's syndrome caused by a well differentiated ACTH-secreting neuroendocrine carcinoma of the ileum
    • Singer J, Werner F, Koch CA, Bartels M, Aigner T, Lincke T, et al. Ectopic Cushing's syndrome caused by a well differentiated ACTH-secreting neuroendocrine carcinoma of the ileum. Exp Clin Endocrinol Diabetes 2010;118(8):524-9.
    • (2010) Exp Clin Endocrinol Diabetes , vol.118 , Issue.8 , pp. 524-529
    • Singer, J.1    Werner, F.2    Koch, C.A.3    Bartels, M.4    Aigner, T.5    Lincke, T.6
  • 141
    • 77749270829 scopus 로고    scopus 로고
    • Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropinsecreting tumors
    • Zemskova MS, Gundabolu B, Sinaii N, Chen CC, Carrasquillo JA, Whatley M, et al. Utility of various functional and anatomic imaging modalities for detection of ectopic adrenocorticotropinsecreting tumors. J Clin Endocrinol Metab 2010;95(3):1207-19.
    • (2010) J Clin Endocrinol Metab , vol.95 , Issue.3 , pp. 1207-1219
    • Zemskova, M.S.1    Gundabolu, B.2    Sinaii, N.3    Chen, C.C.4    Carrasquillo, J.A.5    Whatley, M.6
  • 143
    • 84872117156 scopus 로고    scopus 로고
    • Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia
    • Froeling V, Elgeti F, Maurer MH, Scheurig-Muenkler C, Beck A, Kroencke TJ, et al. Impact of Ga-68 DOTATOC PET/CT on the diagnosis and treatment of patients with multiple endocrine neoplasia. Ann Nucl Med 2012;26(9):738-43.
    • (2012) Ann Nucl Med , vol.26 , Issue.9 , pp. 738-743
    • Froeling, V.1    Elgeti, F.2    Maurer, M.H.3    Scheurig-Muenkler, C.4    Beck, A.5    Kroencke, T.J.6
  • 144
    • 0037329190 scopus 로고    scopus 로고
    • Localization of medullary thyroid carcinoma metastasis in a multiple endocrine neoplasia type 2A patient by 6-[18F]- fluorodopamine positron emission tomography
    • Gourgiotis L, Sarlis NJ, Reynolds JC, VanWaes C, Merino MJ, Pacak K. Localization of medullary thyroid carcinoma metastasis in a multiple endocrine neoplasia type 2A patient by 6-[18F]- fluorodopamine positron emission tomography. J Clin Endocrinol Metab 2003;88(2):637-41.
    • (2003) J Clin Endocrinol Metab , vol.88 , Issue.2 , pp. 637-641
    • Gourgiotis, L.1    Sarlis, N.J.2    Reynolds, J.C.3    Vanwaes, C.4    Merino, M.J.5    Pacak, K.6
  • 147
    • 77951815580 scopus 로고    scopus 로고
    • Value of combined 6-[18F]fluorodihydroxyphenylalanine PET/CT for imaging of neuroendocrine tumours
    • Schiesser M, Veit-Haibach P, Muller MK, Weber M, Bauerfeind P, Hany T, et al. Value of combined 6-[18F]fluorodihydroxyphenylalanine PET/CT for imaging of neuroendocrine tumours. Br J Surg 2010;97(5):691-7.
    • (2010) Br J Surg , vol.97 , Issue.5 , pp. 691-697
    • Schiesser, M.1    Veit-Haibach, P.2    Muller, M.K.3    Weber, M.4    Bauerfeind, P.5    Hany, T.6
  • 150
    • 0005924729 scopus 로고    scopus 로고
    • Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: A case-control study
    • Sanduleanu S, Stridsberg M, Jonkers D, Hameeteman W, Biemond I, Lundqvist G, et al. Serum gastrin and chromogranin A during medium- and long-term acid suppressive therapy: a case-control study. Aliment Pharmacol Ther 1999;13(2):145-53.
    • (1999) Aliment Pharmacol Ther , vol.13 , Issue.2 , pp. 145-153
    • Sanduleanu, S.1    Stridsberg, M.2    Jonkers, D.3    Hameeteman, W.4    Biemond, I.5    Lundqvist, G.6
  • 151
    • 84866145912 scopus 로고    scopus 로고
    • Effect of short-term proton pump inhibitor treatment and its discontinuation on chromogranin A in healthy subjects
    • Mosli HH, Dennis A, Kocha W, Asher LJ, Van Uum SH. Effect of short-term proton pump inhibitor treatment and its discontinuation on chromogranin A in healthy subjects. J Clin Endocrinol Metab 2012;97(9):E1731-5.
    • (2012) J Clin Endocrinol Metab , vol.97 , Issue.9
    • Mosli, H.H.1    Dennis, A.2    Kocha, W.3    Asher, L.J.4    Van Uum, S.H.5
  • 152
    • 84859965815 scopus 로고    scopus 로고
    • A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humans
    • Raines D, Chester M, Diebold AE, Mamikunian P, Anthony CT, Mamikunian G, et al. A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humans. Pancreas 2012;41(4):508-11.
    • (2012) Pancreas , vol.41 , Issue.4 , pp. 508-511
    • Raines, D.1    Chester, M.2    Diebold, A.E.3    Mamikunian, P.4    Anthony, C.T.5    Mamikunian, G.6
  • 153
    • 0025072263 scopus 로고
    • New solid-phase enzyme immunoassay of neuron-specific enolase in serum: Effect of storage temperature, lipemia, icterus, and hemolysis
    • Mercer DW, Virji MA, Barry GE, Piper ML. New solid-phase enzyme immunoassay of neuron-specific enolase in serum: effect of storage temperature, lipemia, icterus, and hemolysis. Clin Chem 1990;36(8 Pt 1):1519.
    • (1990) Clin Chem , vol.36 PART 1 , Issue.8 , pp. 1519
    • Mercer, D.W.1    Virji, M.A.2    Barry, G.E.3    Piper, M.L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.